Granville Biomedical: Expanding Access to Women’s Health Education Worldwide
At Bounce Health Innovation, we celebrate visionary companies that are reshaping healthcare in bold, transformative ways. One of those success stories is Granville Biomedical, a Newfoundland and Labrador-based company that is breaking new ground in women’s health education—now reaching over 28 countries around the world.
Founded with a clear mission to improve access to high-quality educational tools for women’s health, Granville Biomedical designs anatomically accurate pelvic health models that empower healthcare professionals and patients alike. What began as a small effort to address gaps in clinical training has evolved into a global operation, with their products now used by institutions, educators, and healthcare practitioners worldwide.
Granville Biomedical’s flagship products, including the Venus Diversity Trio and the Iris Pessary & Device Demonstration Model, provide realistic, inclusive representations of anatomy in varying skin tones and for diverse patient populations. These models enable clinicians to practice procedures, demonstrate devices, and educate patients in ways that are both accurate and accessible—helping to destigmatize topics that are often overlooked.
This innovation is making a tangible impact. Healthcare providers from universities to clinics are integrating Granville’s models into training and patient care programs, enhancing clinical confidence and improving patient outcomes. By offering tools that are anatomically precise and culturally inclusive, Granville Biomedical is equipping healthcare professionals with the resources to provide high-quality, equitable care—whether they are in St. John’s, Birmingham, or beyond.
Closer to home, Granville Biomedical is helping to strengthen education and awareness around women’s health across Newfoundland and Labrador. Their success demonstrates the potential of Atlantic Canadian innovation to not only fill local gaps but also influence global healthcare practices.
In 2025, Granville Biomedical celebrated a major milestone: their expansion into 28 countries. This growth reflects both the demand for their high-quality educational tools and the company’s commitment to advancing women’s health on an international scale. It’s a testament to how a local vision can have a worldwide impact.
At Bounce, we’re proud to support Granville Biomedical as they continue to empower healthcare providers, educators, and patients around the globe. Their work is a shining example of how Atlantic Canadian innovation is shaping the future of medicine—not just in our region, but internationally.